Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shegokar

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Die Pharmazie|May 27, 2011
Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirsR Shegokar, K K Singh
Die Pharmazie|June 25, 2011
Nevirapine nanosuspensions for HIV reservoir targetingR Shegokar, K K Singh
Die Pharmazie|June 25, 2011
SiRNA delivery: challenges and role of carrier systemsR Shegokar, L Al Shaal, P R Mishra
Die Pharmazie|February 3, 2011
smartCrystal combination technology--scale up from lab to pilot scale and long term stabilityL Al Shaal, R H Müller, R Shegokar
International Journal of Pharmaceutics|August 24, 2010
Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scaleR Shegokar, K K Singh, R H Müller
Indian Journal of Pathology & Microbiology|April 1, 2009
Pulmonary cryptosporidiosis in HIV negative, immunocompromised hostS N Shrikhande, C A Chande, V R Shegokar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 17, 2012
Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN)S Doktorovova, R Shegokar, P Martins-Lopes, et al.
Indian Journal of Medical Microbiology|March 1, 2006
A rare case of human trypanosomiasis caused by Trypanosoma evansiR M Powar, V R Shegokar, P P Joshi, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 4, 2006
Treatment and follow-up of the first case of human trypanosomiasis caused by Trypanosoma evansi in IndiaP P Joshi, A Chaudhari, V R Shegokar, et al.
International Journal of Pharmaceutics|September 13, 2011
Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studiesS Doktorovova, R Shegokar, E Rakovsky, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Die Pharmazie|May 27, 2011
Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirsR Shegokar, K K Singh
Die Pharmazie|June 25, 2011
Nevirapine nanosuspensions for HIV reservoir targetingR Shegokar, K K Singh
Die Pharmazie|June 25, 2011
SiRNA delivery: challenges and role of carrier systemsR Shegokar, L Al Shaal, P R Mishra
Die Pharmazie|February 3, 2011
smartCrystal combination technology--scale up from lab to pilot scale and long term stabilityL Al Shaal, R H Müller, R Shegokar
International Journal of Pharmaceutics|August 24, 2010
Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scaleR Shegokar, K K Singh, R H Müller
Indian Journal of Pathology & Microbiology|April 1, 2009
Pulmonary cryptosporidiosis in HIV negative, immunocompromised hostS N Shrikhande, C A Chande, V R Shegokar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 17, 2012
Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN)S Doktorovova, R Shegokar, P Martins-Lopes, et al.
Indian Journal of Medical Microbiology|March 1, 2006
A rare case of human trypanosomiasis caused by Trypanosoma evansiR M Powar, V R Shegokar, P P Joshi, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 4, 2006
Treatment and follow-up of the first case of human trypanosomiasis caused by Trypanosoma evansi in IndiaP P Joshi, A Chaudhari, V R Shegokar, et al.
International Journal of Pharmaceutics|September 13, 2011
Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studiesS Doktorovova, R Shegokar, E Rakovsky, et al.
Pageof 2